Suppr超能文献

精准医学与正电子发射断层显像/计算机断层扫描:挑战与实施

Precision Medicine and PET/Computed Tomography: Challenges and Implementation.

作者信息

Subramaniam Rathan M

机构信息

Department of Radiology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-8896, USA; Department of Clinical Sciences, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-8896, USA; Department of Biomedical Engineering, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-8896, USA; Advanced Imaging Research Center, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-8896, USA; Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins School of Medicine, Johns Hopkins University, 601 North Caroline Street, Baltimore, MD 21287, USA.

出版信息

PET Clin. 2017 Jan;12(1):1-5. doi: 10.1016/j.cpet.2016.08.010. Epub 2016 Sep 30.

Abstract

Precision Medicine is about selecting the right therapy for the right patient, at the right time, specific to the molecular targets expressed by disease or tumors, in the context of patient's environment and lifestyle. Some of the challenges for delivery of precision medicine in oncology include biomarkers for patient selection for enrichment-precision diagnostics, mapping out tumor heterogeneity that contributes to therapy failures, and early therapy assessment to identify resistance to therapies. PET/computed tomography offers solutions in these important areas of challenges and facilitates implementation of precision medicine.

摘要

精准医学是指在患者的环境和生活方式背景下,针对疾病或肿瘤所表达的分子靶点,在正确的时间为正确的患者选择正确的治疗方法。肿瘤学中精准医学的一些挑战包括用于富集精准诊断的患者选择生物标志物、确定导致治疗失败的肿瘤异质性,以及早期治疗评估以识别对治疗的耐药性。正电子发射断层显像/计算机断层扫描(PET/CT)在这些重要的挑战领域提供了解决方案,并促进了精准医学的实施。

相似文献

1
Precision Medicine and PET/Computed Tomography: Challenges and Implementation.
PET Clin. 2017 Jan;12(1):1-5. doi: 10.1016/j.cpet.2016.08.010. Epub 2016 Sep 30.
2
Molecular Imaging and Precision Medicine: PET/Computed Tomography and Therapy Response Assessment in Oncology.
PET Clin. 2017 Jan;12(1):105-118. doi: 10.1016/j.cpet.2016.08.002. Epub 2016 Oct 5.
3
Precision Medicine and PET/Computed Tomography: Time Has Arrived.
PET Clin. 2017 Jan;12(1):xiii. doi: 10.1016/j.cpet.2016.10.001.
4
Molecular Imaging and Precision Medicine in Lung Cancer.
PET Clin. 2017 Jan;12(1):53-62. doi: 10.1016/j.cpet.2016.08.008. Epub 2016 Sep 10.
5
PET-Based Personalized Management in Clinical Oncology: An Unavoidable Path for the Foreseeable Future.
PET Clin. 2016 Jul;11(3):203-7. doi: 10.1016/j.cpet.2016.03.002. Epub 2016 May 2.
7
Precision Medicine and PET/Computed Tomography in Melanoma.
PET Clin. 2017 Oct;12(4):449-458. doi: 10.1016/j.cpet.2017.05.002. Epub 2017 Jul 14.
8
Total-body PET/CT: how will it change theranostics in oncology?
Expert Rev Med Devices. 2023 Jul-Dec;20(12):999-1003. doi: 10.1080/17434440.2023.2281660. Epub 2023 Nov 24.
9
Molecular Imaging and Precision Medicine in Breast Cancer.
PET Clin. 2017 Jan;12(1):39-51. doi: 10.1016/j.cpet.2016.08.001. Epub 2016 Oct 4.
10
Molecular Imaging and Precision Medicine in Prostate Cancer.
PET Clin. 2017 Jan;12(1):83-92. doi: 10.1016/j.cpet.2016.08.004. Epub 2016 Sep 9.

引用本文的文献

1
Molecular Eye: A System for Precise Diagnosis and Treatment of Major Clinical Diseases Based on Molecular Probe Technology.
Chem Biomed Imaging. 2023 Nov 15;2(3):168-184. doi: 10.1021/cbmi.3c00093. eCollection 2024 Mar 25.
2
A Review of Machine Learning Approaches for Brain Positron Emission Tomography Data Analysis.
Nucl Med Mol Imaging. 2024 Jun;58(4):203-212. doi: 10.1007/s13139-024-00845-6. Epub 2024 Feb 6.
3
PET Oncological Radiopharmaceuticals: Current Status and Perspectives.
Molecules. 2022 Oct 11;27(20):6790. doi: 10.3390/molecules27206790.
4
Evaluation of a High-Sensitivity Organ-Targeted PET Camera.
Sensors (Basel). 2022 Jun 21;22(13):4678. doi: 10.3390/s22134678.

本文引用的文献

1
Anti-3-18F-FACBC (18F-Fluciclovine) PET/CT of Breast Cancer: An Exploratory Study.
J Nucl Med. 2016 Sep;57(9):1357-63. doi: 10.2967/jnumed.115.171389. Epub 2016 Apr 7.
2
18F-FDG PET/CT: Therapy Response Assessment Interpretation (Hopkins Criteria) and Survival Outcomes in Lung Cancer Patients.
J Nucl Med. 2016 Jun;57(6):855-60. doi: 10.2967/jnumed.115.165480. Epub 2016 Feb 2.
4
Repeatability of hypoxia PET imaging using [¹⁸F]HX4 in lung and head and neck cancer patients: a prospective multicenter trial.
Eur J Nucl Med Mol Imaging. 2015 Nov;42(12):1840-9. doi: 10.1007/s00259-015-3100-z. Epub 2015 Jul 2.
5
6
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.
Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):328-54. doi: 10.1007/s00259-014-2961-x. Epub 2014 Dec 2.
9
Head and neck squamous cell cancer (stages III and IV) induction chemotherapy assessment: value of FDG volumetric imaging parameters.
J Med Imaging Radiat Oncol. 2014 Feb;58(1):18-24. doi: 10.1111/1754-9485.12081. Epub 2013 Jun 3.
10
The causes and consequences of genetic heterogeneity in cancer evolution.
Nature. 2013 Sep 19;501(7467):338-45. doi: 10.1038/nature12625.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验